Benevich Eric's Form 4 filing
Neurocrine Biosciences Inc (NBIX) · filed Mar 15, 2024
- Accession no.
- 0000914475-24-000096
- Filed
- Mar 15, 2024
- Trade date
- Mar 14, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $10.5M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Benevich EricCIK 0001643653 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2024 | Common Stock | MOption exerciseAcquired | +5,479 | $79.02 | +$432,950.58 | 46,257 | Direct | |
| Mar 14, 2024 | Common Stock | SSaleDisposed | −5,479 | $139.38 | −$763,663.02 | 40,778 | Direct | |
| Mar 14, 2024 | Common Stock | MOption exerciseAcquired | +69,521 | $81.05 | +$5,634,677.05 | 110,299 | Direct | |
| Mar 14, 2024 | Common Stock | SSaleDisposed | −69,521 | $139.38 | −$9,689,836.98 | 40,778 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2024 | Common Stock | MOption exerciseDisposed | −5,479 | $79.02 | −$432,950.58 | 33,881 | Direct | |
| Mar 14, 2024 | Common Stock | MOption exerciseDisposed | −69,521 | $81.05 | −$5,634,677.05 | 12,587 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.